Nanjing Bioheng Biotech Co., Ltd.
北恒生物
Nanjing Bioheng Biotech Co., Ltd.
Biotech/Healthcare
Beiheng Biopharma is an innovative biopharmaceutical company focused on the development and commercialization of off-the-shelf (universal) cell therapy products, primarily in tumor cell immunotherapy R&D and health genetic testing. With genetic testing and tumor cell immunotherapy as its R&D core…
Latest round: Series B (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.